Prime Minister Announces £20m Fund to Boost UK Medicines Manufacturing

The Prime Minister has announced a new fund to strengthen the UK’s ability to respond to future pandemics. The Medicines and Diagnostic Manufacturing Transformation Fund is designed to expand medicines manufacturing in the UK and create thousands of skilled jobs.

The new capital investment scheme will grow and strengthen the UK’s capabilities, by encouraging companies to develop new technologies, build new factories and harness new advances, including bioprocessing, data and using greener manufacturing processes.

The multi-year programme will have an initial pot of £20 million, which will be available from 2021, as part of the Government’s 2021/2022 Spending Review announced by the Chancellor on 25 November.

Eligible manufacturing companies in England, Scotland and Wales can bid for the fund to help with their capital costs.

Boris Johnson said:

‘This new £20m fund will significantly increase the capacity and resilience of our medicines and diagnostics manufacturing supply chains and equip us to fight future health crises.

Throughout the pandemic we have seen a coming together of British scientific industry and innovation and this new fund will enhance the UK’s manufacturing capabilities even further.’

More information will be made available over the coming months, ahead of the fund launching mid-next year.

GRANTfinder provides up-to-the minute content, insight and analysis on funding news and policy. To find out more about how GRANTfinder can keep you in the know, and subscription fees, contact us today.